122 related articles for article (PubMed ID: 8906296)
1. 4-chloro-3-hydroxyanthranilate attenuate quinolinic acid accumulation in brain following transient cerebral ischemia in the gerbil.
Saito K; Seishima M; Noma A; Suyama K; Markey SP; Heyes MP
Adv Exp Med Biol; 1996; 398():407-11. PubMed ID: 8906296
[No Abstract] [Full Text] [Related]
2. 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.
Saito K; Markey SP; Heyes MP
Neurosci Lett; 1994 Sep; 178(2):211-5. PubMed ID: 7824198
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
Saito K; Nowak TS; Markey SP; Heyes MP
J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
[TBL] [Abstract][Full Text] [Related]
4. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
[TBL] [Abstract][Full Text] [Related]
5. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Naritsin DB; Saito K; Markey SP; Chen CY; Heyes MP
J Neurochem; 1995 Nov; 65(5):2217-26. PubMed ID: 7595510
[TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid 3,4-dioxygenase inhibitor NCR-631.
Fornstedt-Wallin B; Lundström J; Fredriksson G; Schwarcz R; Luthman J
Eur J Pharmacol; 1999 Dec; 386(1):15-24. PubMed ID: 10611459
[TBL] [Abstract][Full Text] [Related]
9. Regulation of quinolinic acid in the normal rat brain by kynurenine pathway precursors.
Luthman J; Vänerman E; Fredriksson G; Fornstedt-Wallin B
Adv Exp Med Biol; 1996; 398():229-39. PubMed ID: 8906270
[No Abstract] [Full Text] [Related]
10. Kynurenine pathway metabolism in the galactosamine model of hepatic injury.
Saito K; Seishima M; Noma A; Nagamura Y; Quearry BJ; Markey SP; Heyes MP
Adv Exp Med Biol; 1996; 398():421-4. PubMed ID: 8906299
[No Abstract] [Full Text] [Related]
11. The kynurenine pathway and neurologic disease. Therapeutic strategies.
Heyes MP
Adv Exp Med Biol; 1996; 398():125-9. PubMed ID: 8906254
[TBL] [Abstract][Full Text] [Related]
12. Temporal and spatial changes of quinolinic acid immunoreactivity in the gerbil hippocampus following transient cerebral ischemia.
Barattè S; Molinari A; Veneroni O; Speciale C; Benatti L; Salvati P
Brain Res Mol Brain Res; 1998 Aug; 59(1):50-7. PubMed ID: 9729272
[TBL] [Abstract][Full Text] [Related]
13. 4-Chloro-3-hydroxyanthranilate inhibits quinolinate production in the rat hippocampus in vivo.
Walsh JL; Wu HQ; Ungerstedt U; Schwarcz R
Brain Res Bull; 1994; 33(5):513-6. PubMed ID: 8186995
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine pathway enzymes in brain. Properties of enzymes and regulation of quinolinic acid synthesis.
Saito K; Heyes MP
Adv Exp Med Biol; 1996; 398():485-92. PubMed ID: 8906309
[No Abstract] [Full Text] [Related]
15. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
Heyes MP; Chen CY; Major EO; Saito K
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
[TBL] [Abstract][Full Text] [Related]
16. 4-chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury.
Yates JR; Heyes MP; Blight AR
J Neurotrauma; 2006 Jun; 23(6):866-81. PubMed ID: 16774472
[TBL] [Abstract][Full Text] [Related]
17. 4-Halo-3-hydroxyanthranilates are potent inhibitors of 3-hydroxyanthranilate oxygenase in the rat brain in vitro and in vivo.
Walsh JL; Todd WP; Carpenter BK; Schwarcz R
Adv Exp Med Biol; 1991; 294():579-82. PubMed ID: 1837691
[No Abstract] [Full Text] [Related]
18. Effects of mitochondria and o-methoxybenzoylalanine on 3-hydroxyanthranilic acid dioxygenase activity and quinolinic acid synthesis.
Chiarugi A; Moroni F
J Neurochem; 1999 Mar; 72(3):1125-32. PubMed ID: 10037484
[TBL] [Abstract][Full Text] [Related]
19. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain.
Kita T; Morrison PF; Heyes MP; Markey SP
J Neurochem; 2002 Jul; 82(2):258-68. PubMed ID: 12124427
[TBL] [Abstract][Full Text] [Related]
20. Non-competitive inhibition of 3-hydroxyanthranilate-3,4-dioxygenase by 4-chloro-3-hydroxyanthranilic acid in whole brain of rat.
Ji XD; Nishimura M; Heyes MP
Adv Exp Med Biol; 1991; 294():563-5. PubMed ID: 1772090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
